Related Experiment Video
Updated: Jun 9, 2026

Stereological and Flow Cytometry Characterization of Leukocyte Subpopulations in Models of Transient or Permanent Cerebral Ischemia
Published on: December 28, 2014
Stroke induces disease-specific myeloid cells in the brain parenchyma and pia
Carolin Beuker1, David Schafflick1, Jan-Kolja Strecker1
1Department of Neurology with Institute of Translational Neurology, Medical Faculty, University Hospital, Münster, Germany.
Abstract:
Inflammation triggers secondary brain damage after stroke. The meninges and other CNS border compartments serve as invasion sites for leukocyte influx into the brain thus promoting tissue damage after stroke. However, the post-ischemic immune response of border compartments compared to brain parenchyma remains poorly characterized. Here, we deeply characterize tissue-resident leukocytes in meninges and brain parenchyma and discover that leukocytes respond differently to stroke depending on their site of residence. We thereby discover a unique phenotype of myeloid cells exclusive to the brain after stroke. These stroke-associated myeloid cells partially resemble neurodegenerative disease-associated microglia. They are mainly of resident microglial origin, partially conserved in humans and exhibit a lipid-phagocytosing phenotype. Blocking markers specific for these cells partially ameliorates stroke outcome thus providing a potential therapeutic target. The injury-response of myeloid cells in the CNS is thus compartmentalized, adjusted to the type of injury and may represent a therapeutic target.
Insights
Immune cells in the brain and meninges respond differently after stroke. A unique myeloid cell type in the brain after stroke presents a potential therapeutic target for stroke recovery.
Area of Science:
- Neuroscience
- Immunology
- Stroke Research
Background:
- Inflammation exacerbates secondary brain damage post-stroke.
- Leukocyte infiltration into the brain occurs via meningeal and CNS border compartments.
- The immune response in CNS border compartments after stroke is not well understood.
Purpose of the Study:
- To characterize resident leukocytes in meninges and brain parenchyma post-stroke.
- To identify distinct immune cell responses based on location within the central nervous system (CNS).
- To discover and validate novel therapeutic targets for stroke treatment.
Main Methods:
- Deep characterization of tissue-resident leukocytes in meninges and brain parenchyma.
- Comparative analysis of myeloid cell phenotypes in different CNS compartments.
- Investigation of stroke-associated myeloid cell markers and their therapeutic potential.
Main Results:
- Leukocytes exhibit differential responses to stroke depending on their resident compartment.
- A unique population of stroke-associated myeloid cells, resembling microglia, was identified exclusively in the brain.
- These myeloid cells, of resident microglial origin, display a lipid-phagocytosing phenotype and are conserved in humans.
- Blocking specific markers on these cells partially improved stroke outcomes.
Conclusions:
- Post-stroke myeloid cell response is compartmentalized within the CNS.
- Stroke-associated myeloid cells represent a novel, targetable mechanism in stroke pathology.
- Targeting these specific myeloid cells offers a potential therapeutic strategy for ameliorating stroke outcomes.
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction

